Stockscreener 앱 받기
0.157
5.42%
-0.009
시간 외 거래:
.15
-0.007
-4.46%
Glycomimetics Inc 주식(GLYC)의 최신 뉴스
GlycoMimetics (GLYC) Trading Halt Sparks Anticipation | GLYC Sto - GuruFocus
GlycoMimetics (GLYC) Trading Halt Sparks Anticipation | GLYC Stock News - GuruFocus
Cantor Fitzgerald Comments on GlycoMimetics FY2026 Earnings - Defense World
GlycoMimetics (NASDAQ:GLYC) Shares to Reverse Split on Monday, June 16th - Defense World
Where Do Analysts Think The GlycoMimetics Inc (NASDAQ: GLYC) Is Going - Stocksregister
Wellington Management Group LLP Takes Position in GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World
GlycoMimetics Stockholders Approve Merger with Crescent Biopharma - TipRanks
GlycoMimetics Stockholders Approve Proposed Merger With Crescent Biopharma And All Related Proposals - marketscreener.com
GlycoMimetics Stockholders Approve Merger with Crescent Biopharma and All Related Proposals - citybiz
GlycoMimetics (GLYC) Stockholders Approve Merger with Crescent Biopharma | GLYC Stock News - GuruFocus
GlycoMimetics announces 1-for-100 reverse stock split - Investing.com Australia
GlycoMimetics announces 1-for-100 reverse stock split By Investing.com - Investing.com Canada
GlycoMimetics stockholders approve proposed Crescent Biopharma merger - TipRanks
GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals - Business Wire
GlycoMimetics Announces Merger Amidst Uncertainties - TipRanks
Crescent Biopharma to Present at the Jefferies Global Healthcare Conference - The Manila Times
GlycoMimetics executives to depart amid merger plans - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDFN, LRFC, RDW, GLYC on Behalf of Shareholders - TradingView
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NDOI, SSBK, BRDG on Behalf of Shareholders - GlobeNewswire Inc.
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com - Defense World
GlycoMimetics (NASDAQ:GLYC) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
GlycoMimetics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc.GLYC - marketscreener.com
GlycoMimetics: Q1 Earnings Snapshot - CT Insider
GLYCOMIMETICS INC SEC 10-Q Report - TradingView
StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World
GlycoMimetics, Inc. to Host Earnings Call - ACCESS Newswire
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerGLYC, BRZH, PRA, FVNNU - The Malaysian Reserve
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – GLYC, BRZH, PRA, FVNNU - TradingView
GLYCGlycomimetics Latest Stock News & Market Updates - Stock Titan
A Stock Analysis Of GlycoMimetics Inc’s (GLYC) - Stocksregister
GlycoMimetics (NASDAQ:GLYC) Coverage Initiated at StockNews.com - Defense World
Ratios Revealed: Decoding GlycoMimetics Inc (GLYC)’s Financial Health - DWinneX
GlycoMimetics Inc (GLYC Stock: A Sea of Opportunity - investchronicle.com
Cantor Fitzgerald initates GlycoMimetics Inc (GLYC) rating to an Overweight - knoxdaily.com
GlycoMimetics Amends Merger Agreement With Crescent Biopharma - Investing.com
GlycoMimetics, Inc. (GLYC) Stock Report: Analyst Ratings Signal Potential in Biotech Space - DirectorsTalk Interviews
Press Release Distribution & PR Platform - ACCESS Newswire
A Look at GlycoMimetics Inc (GLYC) Shares in the Recent Past Indicates Growth - Sete News
GLYC Shares Experience Surge in Value - knoxdaily.com
GlycoMimetics (NASDAQ:GLYC) Stock Price Passes Below 200 Day Moving Average – Time to Sell? - Defense World
GlycoMimetics Inc (GLYC) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Understanding GLYC stock ratios for better investment decisions - uspostnews.com
GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com - Defense World
Wellington Management Group LLP Makes New Investment in GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World
1.91%
1.17%
자본화:
|
볼륨(24시간):